Follow
stefania cicalini
stefania cicalini
INMI Lazzaro Spallanzani
Verified email at inmi.it
Title
Cited by
Cited by
Year
Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022
A Antinori, V Mazzotta, S Vita, F Carletti, D Tacconi, LE Lapini, ...
Eurosurveillance 27 (22), 2200421, 2022
5752022
Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
D Lapa, F Carletti, V Mazzotta, G Matusali, C Pinnetti, S Meschi, ...
The Lancet Infectious Diseases 22 (9), 1267-1269, 2022
2142022
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus
V Puro, G De Carli, S Cicalini, F Soldani, U Balslev, J Begovac, ...
Eurosurveillance 10 (10), 11-12, 2005
1852005
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
P Maggi, A Di Biagio, S Rusconi, S Cicalini, M D’Abbraccio, G d’Ettorre, ...
BMC infectious diseases 17, 1-17, 2017
1762017
Clinical review: new technologies for prevention of intravascular catheter-related infections
S Cicalini, F Palmieri, N Petrosillo
Critical Care 8, 1-6, 2003
1192003
Pathogenesis of HIV‐related pulmonary hypertension
AM Pellicelli, F Palmieri, S Cicalini, N Petrosillo
Annals of the New York Academy of Sciences 946 (1), 82-94, 2001
962001
Infective endocarditis in patients with human immunodeficiency virus infection
S Cicalini, G Forcina, FG De Rosa
Journal of Infection 42 (4), 267-271, 2001
922001
Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with human …
A Antinori, S Cicalini, S Meschi, V Bordoni, P Lorenzini, A Vergori, ...
Clinical Infectious Diseases 75 (1), e552-e563, 2022
872022
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
A Vergori, A Cozzi Lepri, S Cicalini, G Matusali, V Bordoni, S Lanini, ...
Nature Communications 13 (1), 4922, 2022
812022
Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort
A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ...
African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019
692019
Pulmonary hypertension associated with HIV infection: pulmonary vascular disease: the global perspective
S Almodovar, S Cicalini, N Petrosillo, SC Flores
Chest 137 (6), 6S-12S, 2010
692010
Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients
FG De Rosa, S Cicalini, F Canta, S Audagnotto, E Cecchi, G Di Perri
Infection 35, 154-160, 2007
632007
COVID‐19 in people living with HIV: clinical implications of dynamics of the immune response to SARS‐CoV‐2
A Mondi, E Cimini, F Colavita, S Cicalini, C Pinnetti, G Matusali, R Casetti, ...
Journal of medical virology 93 (3), 1796-1804, 2021
622021
Smoking and HIV: time for a change?
N Petrosillo, S Cicalini
BMC medicine 11, 1-4, 2013
552013
Pulmonary hypertension and human immunodeficiency virus infection: epidemiology, pathogenesis, and clinical approach
S Cicalini, S Almodovar, E Grilli, S Flores
Clinical microbiology and infection 17 (1), 25-33, 2011
542011
Post-exposure prophylaxis of HIV infection in healthcare workers: recommendations for the European setting
V Puro, S Cicalini, GD Carli, F Soldani, F Antunes, U Balslev, J Begovac, ...
European Journal of epidemiology 19, 577-584, 2004
542004
Pulmonary cryptosporidiosis in an AIDS patient: successful treatment with paromomycin plus azithromycin
F Palmieri, S Cicalini, N Froio, EB Rizzi, D Goletti, A Festa, G Macri, ...
International journal of STD & AIDS 16 (7), 515-517, 2005
522005
Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
M Camici, P Zuppi, P Lorenzini, L Scarnecchia, C Pinnetti, S Cicalini, ...
International Journal of Infectious Diseases 108, 244-251, 2021
452021
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA
M Zaccarelli, MM Santoro, D Armenia, V Borghi, W Gennari, C Gori, ...
Journal of Clinical Virology 82, 94-100, 2016
432016
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial
M Fabbiani, R Gagliardini, N Ciccarelli, E Quiros Roldan, A Latini, ...
Journal of Antimicrobial Chemotherapy 73 (7), 1955-1964, 2018
412018
The system can't perform the operation now. Try again later.
Articles 1–20